MedPath

NHS BLOOD AND TRANSPLANT

NHS BLOOD AND TRANSPLANT logo
🇬🇧United Kingdom
Ownership
-
Established
2005-01-01
Employees
-
Market Cap
-
Website
https://www.nhsbt.nhs.uk

Convalescent Plasma Donor Vaccine Study An Observational Antibody Level Study.

Conditions
Healthy
First Posted Date
2021-07-08
Last Posted Date
2021-07-15
Lead Sponsor
NHS Blood and Transplant
Target Recruit Count
100
Registration Number
NCT04954937
Locations
🇬🇧

NHSBT - Birmingham Donation Centre, Birmingham, United Kingdom

TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia

Phase 3
Completed
Conditions
Hematologic Neoplasms
Hematopoietic Stem Cell Transplantation
Hemorrhage
Interventions
Drug: Tranexamic acid (TXA).
Drug: Placebo
First Posted Date
2017-05-02
Last Posted Date
2024-12-12
Lead Sponsor
NHS Blood and Transplant
Target Recruit Count
616
Registration Number
NCT03136445
Locations
🇬🇧

Queen Elizabeth Hospital, Birmingham, United Kingdom

🇦🇺

Royal Adelaide Hospital, Adelaide, Australia

🇦🇺

Andrew Love Cancer Centre, Geelong, Australia

and more 23 locations

Notification of Donors With Positive Microbiology Markers

Completed
Conditions
Human Immunodeficiency Virus
Hepatitis B
Hepatitis C
Creutzfeldt-Jakob Syndrome
Human T-lymphotropic Virus I & II
First Posted Date
2010-01-18
Last Posted Date
2022-05-10
Lead Sponsor
NHS Blood and Transplant
Target Recruit Count
217
Registration Number
NCT01050881
Locations
🇬🇧

NHS Blood and Transplant, Transfusion Microbiology, Colindale, London, United Kingdom

Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS)

Phase 3
Terminated
Conditions
Sickle Cell Disease
Interventions
Other: Red blood cell transfusion
First Posted Date
2007-08-07
Last Posted Date
2023-03-23
Lead Sponsor
NHS Blood and Transplant
Target Recruit Count
70
Registration Number
NCT00512577
Locations
🇬🇧

NBS/MRC Clinical Studies Unit, National Blood Service, Cambridge, Cambridgeshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath